Advanced search
1 file | 51.39 KB

Time to initiation of multidrug-resistant tuberculosis treatment and its relation with outcome in a high incidence district in Lima, Peru

Author
Organization
Abstract
Objective: To determine the time from diagnosis to start of multidrug resistant tuberculosis (MDR TB) treatment in Lima, Peru. Methods: We studied new smear-positive TB adults that were started on MDR TB treatment or that were switched to it between June 2008 and December 2011. Results: Time from the first positive smear to MDR-TB treatment was >30days in 35% (13/37) of patients. Among the 27% (24/88) of patients that switched to MDR-TB treatment, time from the last dose of a drug-susceptible regimen was >30days. Conclusion: Start of and switching to MDR TB treatment is still delayed.
Keywords
DIAGNOSIS, XPERT MTB/RIF, multidrug resistant, IMPLEMENTATION, AFRICA, tuberculosis, Peru, time to treatment

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 51.39 KB

Citation

Please use this url to cite or link to this publication:

Chicago
Otero, L, A De Orbegoso, AF Navarro, J Ríos, T Párraga, E Gotuzzo, C Seas, and Patrick Van Der Stuyft. 2015. “Time to Initiation of Multidrug-resistant Tuberculosis Treatment and Its Relation with Outcome in a High Incidence District in Lima, Peru.” Tropical Medicine & International Health 20 (3): 322–325.
APA
Otero, L., De Orbegoso, A., Navarro, A., Ríos, J., Párraga, T., Gotuzzo, E., Seas, C., et al. (2015). Time to initiation of multidrug-resistant tuberculosis treatment and its relation with outcome in a high incidence district in Lima, Peru. TROPICAL MEDICINE & INTERNATIONAL HEALTH, 20(3), 322–325.
Vancouver
1.
Otero L, De Orbegoso A, Navarro A, Ríos J, Párraga T, Gotuzzo E, et al. Time to initiation of multidrug-resistant tuberculosis treatment and its relation with outcome in a high incidence district in Lima, Peru. TROPICAL MEDICINE & INTERNATIONAL HEALTH. 2015;20(3):322–5.
MLA
Otero, L et al. “Time to Initiation of Multidrug-resistant Tuberculosis Treatment and Its Relation with Outcome in a High Incidence District in Lima, Peru.” TROPICAL MEDICINE & INTERNATIONAL HEALTH 20.3 (2015): 322–325. Print.
@article{6997606,
  abstract     = {Objective: To determine the time from diagnosis to start of multidrug resistant tuberculosis (MDR TB) treatment in Lima, Peru. 
Methods: We studied new smear-positive TB adults that were started on MDR TB treatment or that were switched to it between June 2008 and December 2011. 
Results: Time from the first positive smear to MDR-TB treatment was >30days in 35% (13/37) of patients. Among the 27% (24/88) of patients that switched to MDR-TB treatment, time from the last dose of a drug-susceptible regimen was >30days. 
Conclusion: Start of and switching to MDR TB treatment is still delayed.},
  author       = {Otero, L and De Orbegoso, A and Navarro, AF and Ríos, J and Párraga, T and Gotuzzo, E and Seas, C and Van Der Stuyft, Patrick},
  issn         = {1360-2276},
  journal      = {TROPICAL MEDICINE & INTERNATIONAL HEALTH},
  keywords     = {DIAGNOSIS,XPERT MTB/RIF,multidrug resistant,IMPLEMENTATION,AFRICA,tuberculosis,Peru,time to treatment},
  language     = {eng},
  number       = {3},
  pages        = {322--325},
  title        = {Time to initiation of multidrug-resistant tuberculosis treatment and its relation with outcome in a high incidence district in Lima, Peru},
  url          = {http://dx.doi.org/10.1111/tmi.12430},
  volume       = {20},
  year         = {2015},
}

Altmetric
View in Altmetric
Web of Science
Times cited: